Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001203311-22-000018
Filing Date
2022-03-09
Accepted
2022-03-09 19:42:40
Documents
1
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 28416
  Complete submission text file 0001203311-22-000018.txt   29856
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DR SE BOTHELL WA 98021
Business Address
SIEGALL CLAY B (Reporting) CIK: 0001167496 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 22726932